Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-24 | New | $119,999,987 | $119,999,987 | Equity Only | 06b | SEC link |
| 2024-08-23 | New | $13,999,994 | $13,999,994 | Equity Only | 06b | SEC link |
| 2023-06-28 | New | $16,749,994 | $16,749,994 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Heather Christofk | Executive |
| Cathy Friedman | Director |
| Daniel Gil | Director, Executive |
| Richard Heyman | Director |
| William Edward Lowry | Director, Executive |
| Christina Weng | Executive |
| Nathan Wheeler | Executive |